Multimodality Imaging of Pulmonary Hypertension
A special issue of Diagnostics (ISSN 2075-4418). This special issue belongs to the section "Medical Imaging and Theranostics".
Deadline for manuscript submissions: closed (31 March 2022) | Viewed by 3148
Special Issue Editors
Interests: clinical management of pulmonary hypertension; diagnosis and assessment of pulmonary hypertension with a focus on imaging
Interests: clinical application of novel imaging techniques and analysis approaches in patients with cardiac and pulmonary disease
Special Issue Information
Dear Colleagues,
Pulmonary hypertension has many causes and remains a life-shortening condition. Making an accurate diagnosis is key in defining prognosis and treatment, as is the need for ongoing monitoring. Over the last 2 decades, there have been significant advances in imaging techniques, including the emergence of artificial intelligence approaches and an increasingly collaborative approach to research. This Special Issue summarises a range of imaging techniques and their current and potential applications in the assessment and ongoing monitoring or patients with pulmonary hypertension. Included are the application of approaches such as harnessing the power of AI, large data sets and genomics, the use of imaging tools to assess cardiac, lung, and vascular structure and function, and their application to improve our understanding of disease and aid clinical decision making.
Prof. Dr. David G. Kiely
Dr. Andrew J. Swift
Prof. Dr. David L. Levin
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- MRI
- CT
- scintigraphy
- artificial intelligence
- genomics
- pulmonary arterial hypertension
- pulmonary hypertension
- chronic thromboembolic pulmonary hypertension
- right ventricular function
- micro-CT
- 4D flow
- imaging
- COVID-19
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
